Skip to main content
Premium Trial:

Request an Annual Quote

Rare Disease Variants ID'd in Literature Not Always Found in Accessible Databases

Nearly a quarter of variants reported to be pathogenic for X-linked Creatine Transporter Deficiency in articles available in PubMed are not present in public variant databases, according to a new analysis in BMC Genomics. Researchers from the US National Institutes of Health and the Frederick National Laboratory for Cancer Research sifted through the literature to identify 185 unique variants in SLC6A8, the gene affected in X-linked Creatine Transporter Deficiency. The researchers further determined the variants' pathogenicity based on American College of Medical Genetics and Genomics guidelines and searched to see whether the variants were present in databases or datasets like ClinVar, dbSNP, gnomAD, and 1,000 Genomes. Overall, 24 percent of pathogenic variants for X-linked Creatine Transporter Deficiency were not found in an open-access database, a finding the researchers say is likely not restricted to this one disease. "Despite being published in the literature, pathogenicity data on patient variants may remain inaccessible for genetic diagnosis, therapeutic target identification, mechanistic understanding, or hypothesis generation," the researchers write.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.